Download PDF
Previous article
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;
10.1016/j.aohep.2025.102176
Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;
10.1016/j.aohep.2024.101757
Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
Yiyuan Xiao; Sihua Xu; Wenyan Hu; Jiapeng Huang; Deke Jiang; Rong Na; Zhaoqing Yin; Jingjing Zhang; Haitao Chen;
10.1016/j.aohep.2024.101750